Floatz logo

Epsametostat

Epithelioid Sarcoma

Haihe Biopharma Co., Ltd.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Epithelioid Sarcoma cohort.

Asset / SponsorPhaseRating
Tazemetostat
Epizyme, Inc.
Phase 2BB
Nab-Rapamycin
Sarcoma Oncology Research Center, LLC
Phase 1/2CCC
Nivolumab
Sarcoma Oncology Research Center, LLC
Phase 1/2CCC
Tiragolumab
National Cancer Institute (NCI)
Phase 1/2CCC
Zoledronate
University of Florida
Phase 1/2CCC

View all 10 →

Same molecule, other indications

Epsametostat is also rated in:

follicular lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
CC
Indicative ·
43 / 100
View asset →
cancerDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →